<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Neupath Health Inc — News on 6ix</title>
<link>https://6ix.com/company/neupath-health-inc</link>
<description>Latest news and press releases for Neupath Health Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 09 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/neupath-health-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f4a878dffbe2df12edd8.webp</url>
<title>Neupath Health Inc</title>
<link>https://6ix.com/company/neupath-health-inc</link>
</image>
<item>
<title>NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-2026-bloom-burton-and-co-healthcare-investor-conference</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-2026-bloom-burton-and-co-healthcare-investor-conference</guid>
<pubDate>Thu, 09 Apr 2026 11:30:00 GMT</pubDate>
<description>NeuPath Health Inc. (TSXV:NPTH), (&#x201C;NeuPath&#x201D; or the &#x201C;Company&#x201D;) operate...</description>
</item>
<item>
<title>NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-proposed-shares-for-debt-settlement</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-proposed-shares-for-debt-settlement</guid>
<pubDate>Wed, 01 Apr 2026 11:30:00 GMT</pubDate>
<description>- Executives agree to take NeuPath shares to continue to participate in the future upside - ...</description>
</item>
<item>
<title>NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2025 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-fourth-quarter-and-year-end-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-fourth-quarter-and-year-end-2025-results</guid>
<pubDate>Thu, 26 Mar 2026 11:30:00 GMT</pubDate>
<description>Fourth quarter total revenue of $22.1 million, up 17% year-over-year Positive cash flows,...</description>
</item>
<item>
<title>NEUPATH HEALTH TO REPORT 2025 RESULTS AND HOST INVESTOR WEBINAR</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-2025-results-and-host-investor-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-2025-results-and-host-investor-webinar</guid>
<pubDate>Tue, 17 Mar 2026 11:30:00 GMT</pubDate>
<description>TORONTO, March 17, 2026--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it will release its audited financial results for the year ended December 31, 2025 before markets open on Thursday, March 26, 2026. Investors and stakeholders are invited to join a live webinar with Joseph Walewicz, NeuPath’s Chief Executive Officer, Stephen Lemieux, NeuPath’s President and inco</description>
</item>
<item>
<title>NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-executive-leadership-123000770</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-executive-leadership-123000770</guid>
<pubDate>Mon, 26 Jan 2026 12:30:00 GMT</pubDate>
<description>TORONTO, January 26, 2026--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the "Company") today announced the timing and details for a planned leadership transition in 2026, as well as preliminary revenue and Adjusted EBITDA expectations for 2025. As part of its long-term succession planning, NeuPath’s President Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph will continue his role on the Board of Directors and work closely with NeuPath’s leade</description>
</item>
<item>
<title>NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-renewal-of-normal-course-issuer-bid</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-renewal-of-normal-course-issuer-bid</guid>
<pubDate>Thu, 04 Dec 2025 12:30:00 GMT</pubDate>
<description>NeuPath Health Inc. (TSXV:NPTH) ( NeuPath or the &#x201C; Company &#x201D;) announced tod...</description>
</item>
<item>
<title>NEUPATH HEALTH REPORTS THIRD QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-third-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-third-quarter-2025-results</guid>
<pubDate>Thu, 13 Nov 2025 12:30:00 GMT</pubDate>
<description>Third quarter total revenue of $22.1 million, up 26% year-over-year Positive cash flows, ...</description>
</item>
<item>
<title>NEUPATH HEALTH TO REPORT Q3 RESULTS AND HOST INVESTOR WEBINAR</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q3-results-and-host-investor-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q3-results-and-host-investor-webinar</guid>
<pubDate>Mon, 27 Oct 2025 11:30:00 GMT</pubDate>
<description>NeuPath to report Q3 2025 results on November 13 th before markets open NeuPath H...</description>
</item>
<item>
<title>NEUPATH HEALTH TO PRESENT AT THE PLANET MICROCAP SHOWCASE: TORONTO IN PARTNERSHIP WITH THE MICROCAPCLUB ON WEDNESDAY, OCTOBER 22, 2025</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-planet-microcap-showcase-toronto-in-partnership-with-the-microcapclub-on-wednesday-october-22-2025</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-planet-microcap-showcase-toronto-in-partnership-with-the-microcapclub-on-wednesday-october-22-2025</guid>
<pubDate>Wed, 15 Oct 2025 11:30:00 GMT</pubDate>
<description>- 1x1 Meetings Wednesday, October 22 nd and Thursday, October 23 rd - NeuPath...</description>
</item>
<item>
<title>NEUPATH HEALTH TO PRESENT AT THE ANNUAL SMALLCAP DISCOVERIES CONFERENCE IN VANCOUVER</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-annual-smallcap-discoveries-conference-in-vancouver</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-annual-smallcap-discoveries-conference-in-vancouver</guid>
<pubDate>Mon, 22 Sep 2025 11:30:00 GMT</pubDate>
<description>NeuPath Health Inc. (TSXV:NPTH), (&#x201C;NeuPath&#x201D; or the &#x201C;Company&#x201D;), owner ...</description>
</item>
<item>
<title>NEUPATH HEALTH REPORTS SECOND QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-second-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-second-quarter-2025-results</guid>
<pubDate>Thu, 14 Aug 2025 11:30:00 GMT</pubDate>
<description>Record second quarter total revenue of $23.6 million, up 25% year-over-year Positive cash...</description>
</item>
<item>
<title>NEUPATH HEALTH TO REPORT Q2 RESULTS AND HOST INVESTOR WEBINAR</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q2-results-and-host-investor-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q2-results-and-host-investor-webinar</guid>
<pubDate>Thu, 07 Aug 2025 11:30:00 GMT</pubDate>
<description>NeuPath to report Q2 2025 results on August 14 th before markets open NeuPath Hea...</description>
</item>
<item>
<title>NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-voting-results-from-the-annual-general-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-announces-voting-results-from-the-annual-general-and-special-meeting-of-shareholders</guid>
<pubDate>Thu, 12 Jun 2025 11:30:00 GMT</pubDate>
<description>NeuPath Health Inc. (TSXV:NPTH), (&#x201C;NeuPath&#x201D; or the &#x201C;Company&#x201D;), owner ...</description>
</item>
<item>
<title>NEUPATH HEALTH REPORTS FIRST QUARTER 2025 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-first-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-first-quarter-2025-results</guid>
<pubDate>Thu, 15 May 2025 11:30:00 GMT</pubDate>
<description>Record total revenue of $19.3 million, up 11% year-over-year Positive cash flows, with Ad...</description>
</item>
<item>
<title>NEUPATH HEALTH TO REPORT Q1 RESULTS AND HOST INVESTOR WEBINAR</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q1-results-and-host-investor-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-report-q1-results-and-host-investor-webinar</guid>
<pubDate>Wed, 14 May 2025 11:30:00 GMT</pubDate>
<description>NeuPath to report Q1 2025 results on May 15 th before markets open NeuPath Health...</description>
</item>
<item>
<title>NEUPATH HEALTH TO PRESENT AT THE 2025 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-2025-bloom-burton-and-co-healthcare-investor-conference</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-to-present-at-the-2025-bloom-burton-and-co-healthcare-investor-conference</guid>
<pubDate>Mon, 28 Apr 2025 11:30:00 GMT</pubDate>
<description>NeuPath Health Inc. (TSXV:NPTH), (&#x201C;NeuPath&#x201D; or the &#x201C;Company&#x201D;), owner ...</description>
</item>
<item>
<title>NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-appoints-stephen-lemieux-as-president-to-drive-next-phase-of-strategic-growth</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-appoints-stephen-lemieux-as-president-to-drive-next-phase-of-strategic-growth</guid>
<pubDate>Tue, 15 Apr 2025 11:30:00 GMT</pubDate>
<description>New role strengthens executive team&#x2019;s ability to leverage operational turnaround, improved...</description>
</item>
<item>
<title>NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-fourth-quarter-and-year-end-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-reports-fourth-quarter-and-year-end-2024-results</guid>
<pubDate>Thu, 27 Mar 2025 11:30:00 GMT</pubDate>
<description>Fourth quarter total revenue of $18.9 million, up 12% year-over-year Q4 adjusted EBITDA ...</description>
</item>
<item>
<title>NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-secures-new-credit-facilities-to-drive-growth-and-to-refinance-existing-debt</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-secures-new-credit-facilities-to-drive-growth-and-to-refinance-existing-debt</guid>
<pubDate>Thu, 27 Mar 2025 11:00:00 GMT</pubDate>
<description>$13.5 million package, including $7.0 million to accelerate growth via acquisition and working ca...</description>
</item>
<item>
<title>NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID&#xAE;, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS</title>
<link>https://6ix.com/company/neupath-health-inc/news/neupath-health-the-first-north-american-provider-of-arthrosamidandxae-a-revolutionary-injection-for-knee-osteoarthritis</link>
<guid isPermaLink="true">https://6ix.com/company/neupath-health-inc/news/neupath-health-the-first-north-american-provider-of-arthrosamidandxae-a-revolutionary-injection-for-knee-osteoarthritis</guid>
<pubDate>Thu, 06 Mar 2025 12:30:00 GMT</pubDate>
<description>Arthrosamid can provide pain relief for knee osteoarthritis patients for up to four years after a...</description>
</item>
</channel>
</rss>